Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0243064 NOVEL ORAL PHARMACEUTICAL COMPOSITIONS OF TREPROSTINIL
Oral pharmaceutical compositions of treprostinil, a prodrug, or a pharmaceutically acceptable salt thereof are provided. The compositions possess absolute oral...
2016/0243063 METHODS OF INCREASING THE CYTOTOXICITY OF CHEMOTHERAPEUTIC AGENTS WITH MULTISUBSTRATE INHIBITORS OF HISTONE,...
A method of treating cancer in a subject in need thereof, comprising administering to the subject a first amount of a compound of the HAT inhibitor of the...
2016/0243062 SYNTHESIS AND GROWTH REGULATORY ACTIVITY OF A PROTOTYPE MEMBER OF A NEW FAMILY OF AMINOTHIOL RADIOPROTECTORS
The synthesis, growth inhibition and radioprotective activity of the PrC-210 aminothiol, 3-(methyl-amino)-2-((methylamino)methyl)propane-l-thiol, and its ...
2016/0243061 COMPOSITIONS COMPRISING CHOLINE AND DERIVATIVES THEREOF, USES THEREOF AND PROCESSES FOR THEIR PREPARATION
The invention provides compositions comprising choline and water soluble derivatives thereof, processes for their preparation from natural sources and uses...
2016/0243060 METHOD AND COMPOSITIONS FOR DISSOLVING OR SOLUBILIZING THERAPEUTIC AGENTS
The invention provides pharmaceutical compositions comprising a dry medicament. The dry medicaments can be rapidly dissolved, solubilized, and/or reconstituted...
2016/0243059 PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING DEGENERATIVE BRAIN DISEASE COMPRISING MULTI-TARGETING...
A pharmaceutical composition for treating or preventing a degenerative brain disease, the pharmaceutical composition including, as an active component, a...
2016/0243058 COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS
The invention provides methods for treating CNS-related conditions with amantadine and donepezil, in which the amantadine is in an extended release form,...
2016/0243057 METHODS OF STABILIZING THE EXTRACELLULAR MATRIX AND COMPOSITIONS THEREFOR
Disclosed are prophylactic and therapeutic methods, as well as dosing regimens and medicaments for use in preventing chronic disease, for treating acute or...
2016/0243056 Sustained Release Formulations Containing Methylglyoxal and Their Therapeutic Applications
Provided herein is a nano drug composition for the treatment of cancer including 0.125-0.5 mg of methylglyoxal as conjugated to nanoparticles of chitosan, its...
2016/0243055 CANNABIDIOL FOR TREATMENT OF SEVERE AND REFRACTORY GRAFT-VERSUS-HOST DISEASE
The invention provides methods for preventing, ameliorating and treating the acute and chronic forms of graft-versus-host disease (GVHD) by using Cannabidiol...
2016/0243054 SYNERGISTIC THERAPIES OF CANNABIDIOL WITH HYPOTHERMIA FOR NEUROPROTECTION
The present invention relates to the combination of the phytocannabinoid cannabidiol with therapeutic hypothermia for use in the treatment of neuroprotection...
2016/0243053 TRANSDERMAL PATCH AND METHOD FOR DELIVERY OF VITAMIN B12
The present invention is directed to compositions and devices for transdermally administering vitamin B.sub.12 to a subject. In one aspect, a vitamin B.sub.12...
2016/0243051 MONO DISPERSE POLYMER NANOPARTICLES, FUNCTIONALIZED NANOPARTICLES AND CONTROLLED FORMATION METHOD
A method produces polymer nanoparticles. Polymer solution is sprayed through a nozzle toward a collector. An electric field is created at the nozzle, such as...
2016/0243050 CROSSLINKED NANOPARTICLE COMPOSITION
The present invention provides a process for preparing the nanoparticles. The process comprises first forming a water-in-oil emulsion from chitosan lactate,...
2016/0243049 NANORASPBERRIES FOR PHOTOTHERMAL CANCER THERAPY
Compositions and methods for cancer therapy are disclosed. More particularly, the present disclosure relates to tumor-selective chitosan protected gold...
2016/0243048 CATIONIC NANOPARTICLES FOR CO-DELIVERY OF NUCLEIC ACIDS AND THERAPEUTIC AGENTS
Nanoparticles containing an aqueous core containing one or more nucleic acids, such as siRNA, and a shell containing one or more hydrophobic cationic...
2016/0243047 SURFACE FUNCTIONALIZED, HOST-GUEST POLYMER NANO-ASSEMBLIES AND METHODS THEREOF
The invention generally relates to polymer-based nano-structures. More particularly, the invention relates to novel, surface-functionalized, guest-host polymer...
2016/0243046 METHOD OF MAKING PARTICLES FOR USE IN A PHARMACEUTICAL COMPOSITION
The invention relates to a method for making composite active particles for use in a pharmaceutical composition for pulmonary administration, the method...
2016/0243045 DOSAGE FORMS FOR ADMINISTERING COMBINATIONS OF DRUGS
The present invention is directed to dosage forms that can be used in therapeutic methods involving the oral co-administration of a combination of at least two...
2016/0243044 SOFT GELATIN CAPSULES CONTAINING FEXOFENADINE
Bioavailable liquid softgel fill compositions comprising a) fexofenadine or a fexofenadine salt; b) a matrix comprising a pharmaceutically acceptable...
2016/0243043 DEVICE AND METHOD FOR REDUCING CALORIE INTAKE
Devices and methods for substantially reducing the caloric efficiency of the digestive tract by capturing food being digested in the stomach 10 and/or anywhere...
2016/0243042 CONTROLLED-RELEASE FORMULATIONS COMPRISING TORSEMIDE
Disclosed herein are controlled-release (GR, e.g., extended-release (ER) or prolonged-release (PR)) oral dosage formulation comprising an effective amount of...
2016/0243041 GASTRIC RETENTIVE EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS
The present disclosure provides extended release pharmaceutical compositions comprising an opioid and an additional active pharmaceutical ingredient, wherein...
2016/0243040 Pharmaceutical Composition with Antiinflammatory Agents and Production Process
The present invention relates to pharmaceutical compositions including a triphasic release system, which may be delayed release and/or extended release and/or...
2016/0243039 Method Of Making Particles For Use In A Pharmaceutical Composition
A method for making composite excipient particles for use in a pharmaceutical composition comprises a milling step in which particles of an excipient material...
2016/0243038 Controlled-Release Compositions of Melatonin Combined with Sedative and/or Analgesic Ingredients
Controlled-release therapeutic compositions including melatonin combined with sedative and/or analgesic ingredients are described. The compositions have a...
2016/0243037 Polysialic Acid-Polycaprolactone Micelles for Drug Delivery
PSA-PCL micelles were developed as carrier systems for pharmaceutical drugs. As an example, cyclosporine A (CyA) was encapsulated in the micelles and physical...
2016/0243036 FILM DOSAGE FORMS CONTAINING AMORPHOUS ACTIVE AGENTS
Oral thin film dosage form of a stable dispersion of non-solubilized amorphous or partially amorphous active agent(s), having a mean particle size diameter D50...
2016/0243035 COMPOSITIONS FOR THE TREATMENT OF CNS-RELATED CONDITIONS
The invention provides methods for treating CNS-related conditions with amantadine and donepezil, in which the amantadine is in an extended release form,...
2016/0243034 PHARMACEUTICAL COMPOSITION COMPRISING CAPECITABINE AND CYCLOPHOSPHAMIDE
A pharmaceutical compositions having fixed dose combinations of capecitabine and cyclophosphamide, processes for the preparation thereof, and their use to...
2016/0243033 METHODS OF TREATING ABC-DLBCL USING INHIBITORS OF BRUTON'S TYROSINE KINASE
Disclosed herein are methods for treating an individual diagnosed with ABC-DLBCL. The methods include administering to the individual an inhibitor of Bruton's...
2016/0243032 STEROID-CONTAINING SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND RELATED METHODS
Biocompatible intraocular implants include a steroid and an auxiliary agent, where the auxiliary agent is present in an amount sufficient to lessen the...
2016/0243031 PHARMACEUTICAL OPHTHALMIC COMPOSITIONS AND METHODS FOR FABRICATING THEREOF
Pharmaceutical ophthalmic compositions are described, the compositions consisting essentially of a therapeutically effective quantity of an anti-bacterial...
2016/0243030 Aqueous Ophthalmic Composition
The present invention relates to an aqueous ophthalmic composition comprising (A) polyoxyethylene castor oil, (B) polyethylene glycol monostearate, and (C) at...
2016/0243029 METHOD OF TREATING MIDDLE EAR INFECTIONS
Aqueous suspension formulations containing dexamethasone and ciprofloxacin are disclosed for the treatment of middle ear infections in human patients having an...
2016/0243028 Auris Formulations for Treating Otic Diseases and Conditions
Disclosed herein are compositions and methods for the treatment of otic disorders with immunomodulating agents and auris pressure modulators. In these methods,...
2016/0243027 IMPLANTABLE SOLID DOSAGE FORM
A solid dose for insertion into the skin of a patient wherein the solid dose has a hollow core. There is also provided a solid dose carrier, a device, a method...
2016/0243026 COMPOSITIONS, METHODS AND DEVICES FOR LOCAL DRUG DELIVERY
This invention provide novel compositions, methods and devices for sustained drug delivery. The compositions can include a fluid carrier; a plurality of first...
2016/0243025 Topical Formulation for Pain Relief
Described herein are topical pain compositions comprising between 15 and 90% mannitol, for use in the treatment of pain, itch and other cutaneous nerve...
2016/0243024 MEDICINAL AEROSOL FORMULATIONS
Use of particulate bulking agents having an extremely small mass median diameter of less than one micron, preferably less than 300 nm, in pharmaceutical...
2016/0243023 Novel Skin Remodeling Strategy
The present invention relates to a method for identifying materials having an efficacy for improving collagen turnover in the skin. The invention also concerns...
2016/0243022 Use of Fermented Milk Product for Skin Treatment
The use of a fermented milk product comprising non-hydrolysed whey proteins which is substantially free of casein proteins for the purpose of improving skin...
2016/0243021 Collagen-Boosting Compositions And Methods
A topical composition and a method for treating skin to boost collagen production are provided. The composition comprises a collagen-boosting effective amount...
2016/0243020 COMPOSITION
Dry shampoo composition comprising a base and propellant, wherein the base comprises sebum absorber particles, said particles comprising acrylate...
2016/0243019 WATER RESISTANT POLYMERS FOR PERSONAL CARE
Described are personal care compositions comprising a polymer comprising: (a) one or more polymer comprising, as polymerized units, (i) 75% to 35% by weight,...
2016/0243018 TOOTH REMINERALIZATION COMPOSITIONS AND METHODS
Tooth remineralization compositions are provided for preventing and treating tooth decay and dental erosion in a patient. The composition comprises a...
2016/0243017 ORAL CARE COMPOSITION
The disclosed invention relates to a composition for delivery of a payload to an oral cavity. The composition incorporates a payload and is stable under...
2016/0243016 CATIONIC AND NONIONIC SURFACTANT CLEANSING COMPOSITION
An aqueous cleansing composition comprising a cationic surfactant, a nonionic surfactant, and a thickener comprising an alkoxylated methyl glucose ether,...
2016/0243015 SKIN LIGHTENING COMPOSITION
Desired skin colour is a major unmet consumer need around the world and especially in Asia. Consumers particularly desire even skin colour, absence of age...
2016/0243014 Optically Clear Acyl-Isethionate Aqueous Concentrate for Cosmetic Use
The present invention relates to optically clear, aqueous isethionate concentrates comprising sparingly water soluble acyl-isethionate above the water...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.